IL -1 and TNF alpha in the development of COPD
IL -1 和 TNF α 在 COPD 发展中的作用
基本信息
- 批准号:6570354
- 负责人:
- 金额:$ 33.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-12-20 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:apoptosis chronic obstructive pulmonary disease cysteine endopeptidases cytokine receptors elastases elastin fibroblasts gel mobility shift assay genetic transcription interleukin 1 laboratory mouse lung injury nuclear factor kappa beta pathologic process tissue /cell culture tumor necrosis factor alpha
项目摘要
Emphysema is an abnormal enlargement of the respiratory spaces with destruction of the alveolar wall. Accumulating evidence suggests that repair processes involving elastin re-synthesis by interstitial lung fibroblasts limits alveolar damage and perhaps restore alveolar units. This proposal will focus on the inflammatory processes that hinder the repair of the alveolar matrix following injury. Our preliminary data reveal that mice deficient in the interleukin 1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) receptors are more resistant to elastase injury than are wild type mice. We postulate that IL-1beta and TNF- alpha down-regulate elastin mRNA following elastase injury and induce apoptosis in the alveolar wall resulting in alveolar rupture and airspace enlargement. Preliminary data indicate that these mediators function to decrease elastin transcription via cis-acting elements located in the proximal elastin promoter. Electrophoretic gel shift assays utilizing nuclear proteins isolated from untreated and IL-1beta treated fibroblasts implicated NF-kappaB and C/EBP-beta proteins. In this proposal, our first aim will determine the mechanism whereby IL-1beta and TNF- alpha down-regulate elastin transcription. The second aim will characterize the signal transduction pathway utilized by these effector substances to down-regulate tropoelastin mRNA in lung fibroblasts The third aim will further examine the effect of elastolytic injury on mice deficient in the TNF-alpha receptors and type 1 (p80) IL-1beta receptors. We will also use caspace-11 deficient mice to clarify the role of apoptosis in this process. These studies will provide new insights into the pathogenesis of COPD and suggest new treatment options.
肺气肿是一种伴随肺泡壁破坏的呼吸腔异常扩大。越来越多的证据表明,修复过程涉及弹性蛋白再合成的肺间质成纤维细胞限制肺泡损伤,并可能恢复肺泡单位。这项建议将集中在炎症过程中,阻碍修复的肺泡基质损伤后。我们的初步数据显示,白细胞介素1 β(IL-1 β)和肿瘤坏死因子-α(TNF-α)受体缺陷的小鼠比野生型小鼠更能抵抗弹性蛋白酶损伤。我们推测,IL-1 β和TNF-α下调弹性蛋白酶损伤后的弹性蛋白mRNA,并诱导肺泡壁细胞凋亡,导致肺泡破裂和肺泡腔扩大。初步数据表明,这些介质的功能,以减少弹性蛋白转录通过顺式作用元件位于近端弹性蛋白启动子。电泳凝胶位移分析利用从未经处理和IL-1 β处理的成纤维细胞分离的核蛋白,涉及NF-κ B和C/EBP-β蛋白。在这个提议中,我们的第一个目标是确定IL-1 β和TNF-α下调弹性蛋白转录的机制。第二个目标将表征这些效应物质用于下调肺成纤维细胞中弹性蛋白原mRNA的信号转导途径。第三个目标将进一步检查弹性蛋白溶解损伤对TNF-α受体和1型(p80)IL-1 β受体缺陷小鼠的影响。我们还将使用Caspace-11缺陷小鼠来阐明凋亡在这一过程中的作用。这些研究将为COPD的发病机制提供新的见解,并提出新的治疗方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Howard Goldstein其他文献
Ronald Howard Goldstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Howard Goldstein', 18)}}的其他基金
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8543292 - 财政年份:2013
- 资助金额:
$ 33.48万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8682796 - 财政年份:2013
- 资助金额:
$ 33.48万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
9794752 - 财政年份:2013
- 资助金额:
$ 33.48万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8794424 - 财政年份:2013
- 资助金额:
$ 33.48万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8967191 - 财政年份:2013
- 资助金额:
$ 33.48万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6787158 - 财政年份:2002
- 资助金额:
$ 33.48万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6920783 - 财政年份:2002
- 资助金额:
$ 33.48万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6466292 - 财政年份:2002
- 资助金额:
$ 33.48万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6610964 - 财政年份:2002
- 资助金额:
$ 33.48万 - 项目类别:
相似海外基金
ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
- 批准号:
493118 - 财政年份:2023
- 资助金额:
$ 33.48万 - 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
- 批准号:
487508 - 财政年份:2023
- 资助金额:
$ 33.48万 - 项目类别:
Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 33.48万 - 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
- 批准号:
489950 - 财政年份:2023
- 资助金额:
$ 33.48万 - 项目类别:
Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
- 批准号:
23K15702 - 财政年份:2023
- 资助金额:
$ 33.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
- 批准号:
10700228 - 财政年份:2023
- 资助金额:
$ 33.48万 - 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
- 批准号:
10543560 - 财政年份:2022
- 资助金额:
$ 33.48万 - 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测
- 批准号:
10445739 - 财政年份:2022
- 资助金额:
$ 33.48万 - 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
- 批准号:
10772527 - 财政年份:2022
- 资助金额:
$ 33.48万 - 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
- 批准号:
10449417 - 财政年份:2022
- 资助金额:
$ 33.48万 - 项目类别: